156 results
Page 4 of 8
8-K
EX-10.3
jlbe zslz
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-99.1
qw825pqfrx9er
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
rt8kvkocwr3q4
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
lm70slk0
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
caezcemkz8njke79
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-10.3
0v6xy0
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
zc6 m96uwvo
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
gdq657ytw0u75a8jtz
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
gnxt o0fsw0cmor12pqs
24 Jun 20
Business combination disclosure
4:03pm
425
jp0v3l115bugxgm94
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.3
pmr1 ots2p1
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
txgz7m 1g96r
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
j4a idi3ec990y
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
9aaix10jqu2965jir6u
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm